EyePoint Pharmaceuticals Inc. buy JPMorgan Chase & Co.
Start price
04.06.24
/
50%
€8.46
Target price
04.06.25
€29.43
Performance (%)
-15.94%
End price
05.06.25
€7.11
Summary
This prediction ended on 05.06.25 with a price of €7.11. The price of EyePoint Pharmaceuticals Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -15.94%. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| EyePoint Pharmaceuticals Inc. | 9.339% | 9.339% | 85.190% |
| iShares Core DAX® | -1.212% | 1.925% | 17.589% |
| iShares Nasdaq 100 | -4.714% | -1.810% | 0.450% |
| iShares Nikkei 225® | -2.976% | -2.660% | 10.156% |
| iShares S&P 500 | -2.744% | -0.448% | 0.320% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread EyePoint Pharmaceuticals Inc. diskutieren
EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) had its price target lowered by analysts at JPMorgan Chase & Co. from $35.00 to $32.00. They now have an "overweight" rating on the stock.
Ratings data for EYPT provided by MarketBeat
In the thread Trading EyePoint Pharmaceuticals Inc.
Die von JPMorgan_Chase___Co_ gewählte maximale Laufzeit wurde überschritten
Stopped prediction by JPMorgan_Chase___Co_ for EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€7.68
13.08.24
13.08.24
€26.50
13.08.25
13.08.25
18.65%
14.08.25
14.08.25
EyePoint Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€21.60
22.01.24
22.01.24
€32.12
22.01.25
22.01.25
-61.75%
23.01.25
23.01.25